Estudio piloto de la prevalencia de síndrome metabólico en estudiantes de la institución universitaria Colegio Mayor de Antioquia en Medellín y la Universidad de Santander. Cúcuta, Colombia
| dc.contributor.author | Gómez Rave, Lyz Jenny | |
| dc.contributor.author | Sierra -Castrillo, Jhoalmis | |
| dc.contributor.author | Bermúdez Pirela, Valmore | |
| dc.contributor.author | Román Marín, Laura | |
| dc.contributor.author | Rojas, Joselyn | |
| dc.date.accessioned | 2019-07-17T22:43:11Z | |
| dc.date.available | 2019-07-17T22:43:11Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Antecedentes: El síndrome metabólico (SM) es una condición que predispone al individuo al desarrollo de enfermedades cardiovasculares, diabetes mellitus tipo 2 y sus complicaciones. Debido a que su prevalencia se encuentra en aumento, se ha convertido en un problema de salud mundial que debe manejarse desde la prevención temprana y la promoción de hábitos saludables. Objetivo: Determinar la prevalencia de SM en un grupo de jóvenes universitarios de la Institución Universitaria Colegio Mayor de Antioquia y la Universidad de Santander. Diseño y método: la investigación es de tipo descriptivo y transversal con una muestra conformada por 80 estudiantes (16 hombres y 64 mujeres), entre los 17 y 32 años, aparentemente sanos. Utilizando la definición de la IDF para el SM, se midieron variables como circunferencia de cintura (CC), presión arterial sistólica y diastólica (PS, PD), glucosa en ayunas (GA), colesterol HDL (HDLc) y triglicéridos (TG). Para el análisis estadístico, la comparación entre grupos se realizó con la medida no paramétrica prueba U de Mann-Whitney, con un nivel de significaticancia p<0,005 y mediante el uso del programa estadístico SPSS versión 24. Resultados: se encontró una prevalencia de SM de 5 %, y en el análisis individual de sus componentes o factores de riesgo asociados se evidenció una mayor prevalencia para CC y GA elevada (38,89% en cada una), seguida de la disminución del HDLc (27,78%). Conclusiones: estos hallazgos concuerdan con estudios previos donde se estima que el SM está presente en adultos jóvenes de acuerdo con criterios de la IDF. A partir de esto se recomienda adoptar medidas institucionales que promuevan la actividad física y la alimentación saludable. | spa |
| dc.description.abstract | Antecedents: Metabolic syndrome (Metsyn) is a condition that predisposes an individual to the development of cardiovascular disease, type 2 diabetes mellitus and its complications. Because its prevalence is increasing, it has become a global health problem that must be managed from early prevention and promotion of healthy habits. Objective: this study determined the prevalence of (Metsyn) in a group of young university students from the University Institution Colegio Mayor de Antioquia y la Universidad de Santander. Design and method: the research is descriptive and cross-sectional with a sample of 80 students (16 men and 64 women), between the ages of 17 and 32, apparently healthy. Using the IDF definition for Metsyn, variables such as waist circumference (WC), systolic and diastolic blood pressure (SP, DP), fasting glucose (FG), HDL cholesterol (HDLc) and triglycerides (TG) were measured. For statistical analysis, comparison between groups was performed with the non-parametric measure Mann- Whitney U test, significant level p<0.005 and the statistics program used was SPSS see 24. Results: MetSyn prevalence was found to be 5%, and individual analysis of its components or associated risk factors showed a higher prevalence for high WC and FG (38.89% in each), followed by the decrease of HDLc (27.78%). Conclusions: These findings are consistent with previous studies where MetSyn is estimated to be present in young adults according to IDF criteria. Based on this, it is recommended to adopt institutional measures that promote physical activity and healthy eating. | eng |
| dc.identifier.issn | 18564550 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/3564 | |
| dc.language.iso | spa | spa |
| dc.publisher | Sociedad Latinoamericana de Hipertensión | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | eng |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.source | Revista Latinoamericana de Hipertensión | spa |
| dc.source | Vol. 14 No. 2 (2019) | spa |
| dc.source.uri | http://caelum.ucv.ve/ojs/index.php/rev_lh/article/view/16348 | spa |
| dc.subject | Síndrome metabólico | spa |
| dc.subject | Diabetes mellitus tipo 2 | spa |
| dc.subject | Hipertensión | spa |
| dc.subject | Obesidad | spa |
| dc.subject | Metabolic syndrome | eng |
| dc.subject | Type 2 diabetic mellitus | eng |
| dc.subject | Hypertension | eng |
| dc.subject | Obesity | eng |
| dc.title | Estudio piloto de la prevalencia de síndrome metabólico en estudiantes de la institución universitaria Colegio Mayor de Antioquia en Medellín y la Universidad de Santander. Cúcuta, Colombia | spa |
| dc.title.alternative | Pilot study of metabolic syndrome prevalence in students of the university institution Colegio Mayor de Antioquia en Medellín y la Universidad de Santander, Cúcuta, Colombia | eng |
| dc.type | article | spa |
| dcterms.references | Akpalu J, Akpalu A, Ofei F. The metabolic syndrome among patients with cardiovascular disease in Accra, Ghana. Ghana Medical Journal. 2011; 45 (4): 161–166. | eng |
| dcterms.references | Gyakobo M, Amoah A, Martey-Marbell D, Snow R. Prevalence of the metabolic syndrome in a rural population in Ghana. BMC Endocrine Disorders. 2012; 12 (25): 1-9. | eng |
| dcterms.references | Chacín Maricarmen, Rojas Quintero Joselyn, Pineda Carlos, Rodríguez Dalla, Núñez P Maryluz, Añez Roberto, Márquez Maria, Leal Nika, Toledo Alexandra, Bermúdez Valmore. Predisposición humana a la obesidad, síndrome metabólico y diabetes: el genotipo ahorrador y la incorporación de los diabetogenes al genoma humano desde la antropología biológica. Síndrome Cardiometabólico. 2011;1:11-25. | spa |
| dcterms.references | Alberti H, Eckel R, Grundy S, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 2009; 120 (16): 1640–1645. | eng |
| dcterms.references | Grundy S, Brewer H, Cleeman J, Smith S, Lenfant C, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/ American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004; 24: 13-18. | eng |
| dcterms.references | Alberti K, Zimmet P, Shaw J. Metabolic syndrome a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetic Medicine. 2006; 23 (5): 469–480. | eng |
| dcterms.references | Anon. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults E and T of HBC in A. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, J. Am. Med. Assoc. 2001; 285 (19): 2486–2497. | eng |
| dcterms.references | Alexander C, Landsman P, Teutsch S, Haffner S. NCEP- defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003; 52 (5): 1210–1214. | eng |
| dcterms.references | Grundy S. Cleeman J. Daniels S. et al. Diagnosis and management of the metabolic syndrome. Circulation. 2005; 112 (17). | eng |
| dcterms.references | Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic síndrome - a new worldwide definition. Lancet. 2005; 366: 1059-1062. | eng |
| dcterms.references | Ford S. Prevalence of the Metabolic Syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005; 28 (11): 2745–2749. | eng |
| dcterms.references | K.G.M.M. Alberti, FRCP; Robert H. Eckel, MD, FAHA; Scott M. Grundy, MD, PhD, FAHA; Paul Z. Zimmet, MD, PhD, FRACP; James I. Cleeman, MD; Karen A. Donato, SM; Jean-Charles Fruchart, PharmD, PhD; W. Philip T. James, MD; Catherine M. Loria, PhD, MS, MA, FAHA; Sidney C. Smith, Jr, MD, FAHA. Harmonizing the Metabolic Syndrome. Joint Scientific Statement. Circulation. 2009;120:1640-1645. | eng |
| dcterms.references | O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes. Rev. 2015; 16 (1): 1–12. | eng |
| dcterms.references | Grundy S. Metabolic syndrome pandemic. Arteriosclerosis, Thrombosis, and Vascular Biology. 2008; 28 (4): 629–636. | eng |
| dcterms.references | Vliet-Ostaptchouk J, Nuotio M, Slagter S, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocrine Disorders. 2014; 14 (1) article 9: 1- 3. | eng |
| dcterms.references | Xi B, He D, Hu Y, Zhou D. Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: the China Health and Nutrition Survey in 2009. Preventive Medicine. 2013; 57 (6): 867–871. | eng |
| dcterms.references | Spencer L. Results of a heart disease risk-factor screening among traditional college students. J Am Coll Hlth. 2002; 50: 291-296. | eng |
| dcterms.references | Fernandes J, Lofgren I. Prevalence of Metabolic Syndrome and individual criteria in college students. J Am Coll Hlth. 2011; 59: 313-321. | eng |
| dcterms.references | Fenwick PH, Jeejeebhoy K, Dhaliwal R, Royall D, Brauer P, Tremblay A, Klein D, Mutch DM. Lifestyle genomics and the metabolic syndrome: a review of genetic variants that influence response to diet and exercise interventions. Critical reviews in food science and nutrition. 2018 Feb 28:1-2. | eng |
| dcterms.references | Yamaoka K, Tango T. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC medicine. 2012 Dec;10(1):138. | eng |
| dcterms.references | Espósito, R. C., de Medeiros, P. J., Silva, F. S., Oliveira, A. G., Soares Aragão, C. F., Oliveira Rocha, H. A., Moreira, S. A., de Farias Sales, V. S. Prevalence of the metabolic syndrome according to different criteria in the male population during the Blue November Campaign in Natal, RN, Northeastern Brazil. Diabetes, metabolic syndrome and obesity: targets and therapy, 11, 401-408. 2018 doi:10.2147/DMSO.S168430 | eng |
| dcterms.references | Mata KR, Bermúdez V, Villalobos E, Guerrero Y, Añez RJ, Rojas J. Prevalencia de las combinaciones de componentes del síndrome metabólico en el municipio San Cristóbal, Táchira, Venezuela. Revista Latinoamericana de Hipertensión. 2017;12(4):117-25. | spa |
| dcterms.references | Bermudez V, Marcano RP, Cano C, Arráiz N, Amell A, Cabrera M, Reyna N, Mengual E, Vega L, Finol F, Luti Y. The Maracaibo city metabolic syndrome prevalence study: design and scope. American Journal of Therapeutics. 2010 May 1;17(3):288-94 | eng |
| dcterms.references | Martínez-Torres Javier, Correa-Bautista Jorge Enrique, González-Ruíz Katherine, Vivas Andrés, Triana-Reina Héctor Reynaldo, Prieto-Benavidez Daniel Humberto, Carrillo Hugo Alejandro, Ramos-Sepúlveda Jeison Alexander, González Emilio Villa, García-Hermoso Antonio, and Ramírez-Vélez Robinson. A Cross-Sectional Study of the Prevalence of Metabolic Syndrome and Associated Factors in Colombian Collegiate Students: The FUPRECOL-Adults Study. Int J Environ Res Public Health. 2017 Mar; 14(3): 233. | eng |
| dcterms.references | Suarez-Ortegón Milton Fabian, Aguilar-de Plata Cecilia. Prevalence of metabolic syndrome in children aged 5-9 years from southwest Colombia: a cross-sectional study. World Journal of Pediatrics. November 2016, Volume 12, Issue 4, pp 477–483. | eng |
| dcterms.references | Organización Panamericana de la Salud y Consejo de Organizaciones Internacionales de las Ciencias Médica. Pautas éticas internacionales para la investigación relacionada con la salud con seres humanos, Cuarta Edición. Ginebra: Consejo de Organizaciones Internacionales de las Ciencias Médicas (CIOMS); 2016. | eng |
| dcterms.references | Nolan P, Carrick-Ranson G, Stinear J, Reading S, Dalleck L. Prevalence of metabolic syndrome and metabolic syndrome components in young adults: A pooled analysis. Preventive Medicine Reports. 2017; 7: 211– 215. | eng |
| dcterms.references | Martínez J, Correa J, González K, Vivas A, Triana H, Prieto D. A Cross- Sectional Study of the Prevalence of Metabolic Syndrome and Associated Factors in Colombian Collegiate Students: The FUPRECOL-Adults Study. Int. J. Environ. Res. Public Health. 2017; 14 (233): 1-14. | eng |
| dcterms.references | Abda, E.; Hamza, L.; Tessema, F.; Cheneke, W. Metabolic syndrome and associated factors among outpatients of Jimma University Teaching Hospital. Diabetes Metab. Syndr. Obes. 2016, 9, 47–53. | eng |
| dcterms.references | De Freitas, R.J.; de Araújo, M.F.; Marinho, N.B.; de Vasconcelos, H.C.; Lima, A.C.; Pereira, D.C.; Almeida, P.C.; Zanetti, M.L.; Damasceno, M.M. Prevalence of the metabolic syndrome and its individual components in Brazilian college students. J. Clin. Nurs. 2013, 22, 1291–1298. | eng |
| dcterms.references | Barbieri, M.A.; Bettiol, H.; Silva, A.A.M.; Cardoso, V.C.; Simões, V.M.F.; Gutierrez, M.R.P.; Castro, J.A.S.; Vianna, E.S.O.; Foss, M.C.; Dos Santos, J.E.; et al. Health in early adulthood: The contribution of the 1978/79 Ribeirão Preto birth cohort. Braz. J. Med. Biol. Res. 2008, 39, 1041–1055. | eng |
| dcterms.references | Ramírez-Vélez, R.; Anzola, A.; Martinez-Torres, J.; Vivas, A.; Tordecilla- Sanders, A.; Prieto-Benavides, D.; Izquierdo, M.; Correa-Bautista, J.E.; Garcia-Hermoso, A. Metabolic Syndrome and Associated Factors in a Population-Based Sample of Schoolchildren in Colombia: The FUPRECOL Study. Metab. Syndr. Relat. Disord. 2016, 14, 455–462. | eng |
| dcterms.references | Fernandes, J.; Lofgren, I. Prevalence of metabolic syndrome and individual criteria in college students. J. Am. Coll. Health 2011, 59, 313– 321. | eng |
| dcterms.references | Bermúdez Valmore, Pacheco Maikol, Rojas Joselyn, Cordova Evelyn, Velazquez Rossibel, Carrillo Daniela, Parra Marıa G. , Toledo Alexandra , Añez Roberto, Fonseca Eneida, Paris Marcano Rafael, Cano Clímaco, Lopez Miranda Jose´ “Epidemiologic behavior of obesity in the Maracaibo City metabolic syndrome prevalence study,” PLoS ONE, vol. 7, no. 4, Article ID e35392, 2012. | eng |
| dcterms.references | F.-V. K. Titty, W. K. B. A. Owiredu, and M. T. Agyei-Frempong, “Prevalence of metabolic syndrome and its individual compo- nents among diabetic patients in Ghana,” Journal of Biological Sciences, vol. 8, no. 6, pp. 1057–1061, 2008. | eng |
| dcterms.references | K. Nsiah, V. Shang, K. Boateng, and F. Mensah, “Prevalence of metabolic syndrome in type 2 diabetes mellitus patients,” International Journal of Applied and Basic Medical Research, vol. 5, no. 2, p. 133, 2015. | eng |
| dcterms.references | O. Adediran, A. Edo, A. Jimoh, and A. Ohwovoriole, “Preva- lence of the metabolic syndrome among Nigerians with type 2 diabetes,” Diabetes International, vol. 15, no. 1, pp. 13–14, 2007. | eng |
| dcterms.references | O’Neill, S., O’Driscoll, L., 2015. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes. Rev. 16 (1):1–12. | eng |
| dcterms.references | Bermúdez Valmore, Rojas Joselyn, Martínez María Sofía, Apruzzese Vanessa, Chávez Castillo Mervin, Gonzalez Robys, Torres, Yaquelín, Salazar Juan, Bello Luis, Añez Roberto, Chacín Maricarmen, Toledo Alexandra, Cabrera Mayela, Mengual Edgardo, Ávila Raquel, Pachano Freddy, and López Miranda José. “Epidemiologic behavior and estimation of an optimal cut-off point for homeostasis model assessment-2 insulin resistance: a report from a Venezuelan population,” International Scholarly Research Notices, vol. 2014, Article ID 616271, 10 pages, 2014 | eng |
| dcterms.references | W. Owiredu, N. Amidu, E. Gockah-Adapoe, and R. Ephraim, “The prevalence of metabolic syndrome among active sports- men/sportswomen and sedentary workers in the Kumasi metropolis,” Journal of Science and Technology (Ghana), vol. 31, no. 1, 2011. | eng |
| dcterms.references | Valero P, Souki A, Arraiz N, Prieto C, Cano C. Resistina y otras adipoquinas: papel en la obesidad, diabetes e insulinoresistencia. En: Bermúdez- Pirela, V, Herazo-Beltrán, Y. (Editores.), Aspectos básicos en obesidad. Barranquilla: Ediciones Universidad Simón Bolívar; 2018. Pp. 19-59. | spa |
| dcterms.references | Sierra J, Gómez L. Asociación de los niveles de adiponectina y del factor de necrosis tumoral-alfa (TNF-α) con la albuminuria en pacientes con diabetes mellitus tipo 2. Medicina & Laboratorio. 2017; 23: 257- 270. | spa |
| dcterms.references | Vásquez HA, Plua W, González L, Alcivar J, Barboza H, Bermúdez- Pírela V,Peña-LE M. Indicadores utilizados en la práctica clínica para el diagnóstico de obesidad. (Editores.), 24 Aspectosbásicos en obesidad. Barranquilla: Ediciones Universidad Simón Bolívar; 2018. Pp. 96-133. | spa |
| dcterms.references | Osei J, Owiredu W, Kwame G, Yao S, Gyamfi J, Alote E, et al. The Prevalence of Metabolic Syndrome and Its Components among People with Type 2 Diabetes in the Ho Municipality, Ghana: A Cross-Sectional Study. International Journal of Chronic Diseases. 2017; 2017: 1-9. | eng |
| dcterms.references | Sabir F, Hassan D, Elamin M. Prevalence of Metabolic Syndrome among Young Sudanese University Students Using Three Different Criteria of WHO, IDF and NCEP-ATP III. Pediatrics and Neonatal Nursing: Open Access. 2016; 2.2: 1-4. | eng |
| dcterms.references | Millán J, Pintó X, Muñoz A, Zúñiga M, Rubíes J, Pallardo L. et al. Cocientes lipoproteicos: significado fisiológico y utilidad de los índices aterogénicos en prevención cardiovascular. Clin Invest Arterioscl. 2010; 22 (1): 25-32. | spa |
| dcterms.references | Yamagishi K, Iso H. The criteria for metabolic syndrome and the national health screening and education system in Japan. 2017; 39: 1-4. | eng |